期刊文献+

PTEN及Caspase-3可能参与卵巢癌铂类耐药的机制 被引量:4

PTEN and Caspase-3 May Be Involved in Cisplatin Drug Resistance in Ovarian Cancer Cells
下载PDF
导出
摘要 目的探讨(phosphatase and tensin homologue deleted on chromosometen,PTEN)PTEN(第10号染色体缺失的磷酸酶及张力蛋白同源的基因)及(半胱氨酸蛋白酶-3)Caspase-3在卵巢癌细胞系A2780,A2780CP(顺铂耐药卵巢癌细胞系)中在顺铂诱导的细胞凋亡过程中的调控作用.方法细胞用10mol/L的顺铂处理24 h,通过Western印迹对PTEN的蛋白水平进行定量分析,观察顺铂处理过的A2780细胞及A2780-CP细胞中PTEN蛋白水平的变化.用Caspase-3抑制剂处理A2780细胞,观察Caspase-3抑制剂是否可恢复PTEN蛋白的水平,来研究PTEN的降解机制.结果 PTEN蛋白水平在A2780细胞显著下降;在顺铂处理过的A2780-CP细胞中PTEN蛋白水平没有变化。相对于于载体处理的细胞(P<0.05).在A2780细胞中,伴随着PTEN蛋白水平的降低,有AKT(分子蛋白激酶B)磷酸化水平(p AKT)水平升高.在A2780细胞,使用caspase-3抑制剂可恢复PTEN蛋白的水平.结论在顺铂处理的卵巢癌A2780细胞中,促凋亡基因PTEN的蛋白的水平的降低和存活因子PAKT水平的升高,能进一步增加A2780细胞的的耐药性. Objective To investigate the regulation of PTEN and Caspase-3 during cisplatin induced apoptosis in A2780, A270-CP (cisplatin resistant) , ovarian cancer cell lines. Methods Cells were treated with 10mol/L of cisplatin for 24 h to observe the change of PTEN protein levels in A2780, A2780-CP ceils with cisplatin treatment. Protein levels were analysed by western blotting, caspase-3 inhibitor were used to observe whether the PTEN protein level could be restored in A2780 cells. And to find the mechanism of PTEN degradation Similar results were observed. Results PTEN protein levels were found to be decreased significantly in A2780 cells; however, there was no change in PTEN protein levels in A2780-CP cells with cisplatin treatment (P〈0.05) . The decrease in PTEN protein was accompanied with an increase in the levels of AKT phosphorylation (pAKT) in A2780 cells. Cisplatin treatment induced the activation/cleavage of caspase-3 in A2780 cells, but there was no change in A2780-CP ceils. In A2780 cells, restoration of PTEN levels was achieved upon pre-treatment with caspases inhibitor. Conclusion The decrease in pro-apoptotic PTEN protein levels and increase in survival factor pAKT in A2780 ovarian cancer ceils suggest that cisplatin treatment could further exacerbate drug resistance in A2780 ovarian cancer cells.
出处 《昆明医科大学学报》 CAS 2017年第3期27-30,共4页 Journal of Kunming Medical University
基金 内蒙古自治区卫生和计划生育委员会科研基金资助项目(201302007)
关键词 顺铂 Caspases-3 癌症 细胞凋亡 PTEN Cisplatin Caspases-3 Cancer Apoptosis PTEN
  • 相关文献

参考文献4

二级参考文献56

  • 1张锦英,束永前,黄普文,刘平,卢凯华,朱陵君,殷咏梅,穆庆霞.抗原负载树突状细胞刺激细胞因子诱导的杀伤细胞治疗晚期胃癌的临床观察[J].中国生化药物杂志,2005,26(6):336-338. 被引量:16
  • 2王欢,周芳坚,王其京,秦自科,黄丽惜,刘卓炜,韩辉,李永强,陈诗萍,夏建川.负载自体肿瘤细胞裂解物的DC疫苗联合CIK治疗晚期肾癌的临床观察——附10例报告[J].癌症,2006,25(5):625-630. 被引量:51
  • 3应敏刚,郑秋红,陈奕贵,谢云青,龚福生,陈路川,吴君心,郑天荣.CIK与DC细胞联合治疗145例晚期恶性实体瘤[J].福建医科大学学报,2007,41(3):218-221. 被引量:19
  • 4Glinsky GV. Genomic models of metastatic cancer: functional a- nalysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chro- matin silencing pathway [ J]. Cell Cycle, 2006,5 ( 11 ) : 1208- 1216.
  • 5Hu J, Liu YL, Piao SL, et al. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer[ J]. Lung Cancer, 2012,77 (3) :593-599.
  • 6Ning J, Zhang J, Liu W, et al. Overexpression of ubiquitin-spe- cific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer [ J ]. Eur J Histochem, 2012,56 ( 4 ) : e46.
  • 7Liu YL, Yang YM, Xu H, et al. Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer[J]. J Surg Oneol, 2011,103(3) :283-289.
  • 8Liu YL, Jiang SX, Yang YM, et al. USP22 Acts as an oncogene by the activation of BMI-l-mediated INK4a/ARF pathway and Akt pathway[J]. Cell Biochem Biophys, 2012,62( 1 ) :229-235.
  • 9Yang DD, Cui BB, Sun LY, et al. The co-expression of USP22 and BMI-1 may promote cancer progression and predict therapy failure in gastric carcinoma[ J]. Cell Biochem Biophys. 2011,61 (3) :703-710.
  • 10Song LB, Li J, Eiao WT, et al. The polycomb group protein Bmi- 1 represses the tumor suppressor PTEN and induces epithelial-me- senchymal transition in human nasopharyngeal epithelial ceils[ J]. J Clin Invest, 2009,119(12) :3626-3636.

共引文献33

同被引文献49

引证文献4

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部